Modified beta thymosin peptides

Details for Australian Patent Application No. 2006204911 (hide)

International Classifications

Event Publications

30 August 2007 PCT application entered the National Phase

PCT publication WO2006/076523 Priority application(s): WO2006/076523

29 November 2007 Change of Name(s) of Applicant(s), Section 104

Regenerx Biopharmaceuticals, Inc.; Universitaet Erlangen-Nuernberg The name of the applicant has been changed to Regenerx Biopharmaceuticals, Inc.; Friedrich Alexander Universitaet Erlangen-Nuernberg

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.